Clinical study of SM-11355 in patients with hepatocellular carcinoma (Phase III Study)
Latest Information Update: 20 Mar 2019
At a glance
- Drugs Epirubicin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 31 May 2016 New trial record